Related content

Antitumor properties of salinomycin on cisplatin-resistant human ovarian cancer cells in vitro and in vivo: involvement of p38 MAPK activation

By            

Oncology Reports, Vol. 29, Iss. 4, 2013-01 ,pp. : 1371-1378

Spandidos Publications

Access to resources Recommend Favorite

Liposomal honokiol, a promising agent for treatment of cisplatin-resistant human ovarian cancer

By Luo Hong  

Journal of Cancer Research and Clinical Oncology, Vol. 134, Iss. 9, 2008-09 ,pp. : 937-945

Springer Publishing Company

Access to resources Recommend Favorite

Knockdown of survivin contributes to antitumor activity in cisplatin-resistant ovarian cancer cells

By        

Molecular Medicine Reports, Vol. 7, Iss. 2, 2013-01 ,pp. : 425-430

Spandidos Publications

Access to resources Recommend Favorite

Effects of p38 MAPK inhibitor on the rat pain behavior and proinflammatory cytokines in a metastatic bone cancer pain model

By Tang Cuiju  

The Chinese-German Journal of Clinical Oncology, Vol. 7, Iss. 3, 2008-03 ,pp. : 154-158

Springer Publishing Company

Access to resources Recommend Favorite

Altered microRNA expression in cisplatin-resistant ovarian cancer cells and upregulation of miR-130a associated with MDR1/P-glycoprotein-mediated drug resistance

By Yang Lingyun   Li Ningwei   Wang Hongjing   Jia Xibiao   Wang Xue   Luo Juan  

Oncology Reports, Vol. 28, Iss. 2, 2012-08 ,pp. : 592-600

Spandidos Publications

Access to resources Recommend Favorite